Shining a Light on Skin Cancer in Inflammatory Bowel Disease: A Role for Prevention

被引：0
|
作者：
Long, Millie D. [1 ]
机构：
[1] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷 / 10期
关键词：
MAINTENANCE THERAPY; RISK; INDUCTION;
D O I：
10.14309/ajg.0000000000000775
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Risks of nonmelanoma skin cancer in patients with inflammatory bowel disease (IBD) have been well described. Newer data have classified risks of subsequent squamous cell carcinoma or basal cell carcinoma in patients with IBD after an initial skin cancer excision. In this editorial, risks of continuing medical therapy for IBD after a skin cancer diagnosis are discussed in the context of a holistic preventive care approach for patients with IBD.
引用
收藏
页码：1607 / 1608
页数：2
相关论文
共 50 条
  • [1] Inflammatory bowel disease and cancer prevention
    Dotan, I
    PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ULCER RESEARCH, 2003, : 123 - 128
  • [2] Prevention of Dysplasia and Cancer in Chronic Inflammatory Bowel Disease: A Role for Chemoprevention
    Zisman, Timothy L.
    Rubin, David T.
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (03) : 43 - 50
  • [3] Cancer in inflammatory bowel disease: is there a chance for cancer prevention?
    Gasche, C.
    Campregher, C.
    Luciani, G.
    STRATEGIES OF CANCER PREVENTION IN GASTROENTEROLOGY, 2009, 165A : 97 - 106
  • [4] Cancer prevention in patients with inflammatory bowel disease
    Itzkowitz, SH
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (04) : 1133 - +
  • [5] Mesalazine and the prevention of colorectal cancer in inflammatory bowel disease
    Bos, C. L.
    Richel, D. J.
    Peppelenbosch, M. P.
    INTESTINAL INFLAMMATION AND COLORECTAL CANCER, 2007, 158 : 226 - 235
  • [6] Nonmelanoma Skin Cancer in Inflammatory Bowel Disease: A Review
    Long, Millie D.
    Kappelman, Michael D.
    Pipkin, Clare A.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1423 - 1427
  • [7] Skin cancer in an Irish inflammatory bowel disease cohort
    Sheridan, J.
    Clowry, J.
    Keegan, D.
    Byrne, K.
    Comber, H.
    Deady, S.
    Cullen, G.
    Mulcahy, H.
    Lally, A.
    Doherty, G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S64 - S65
  • [8] Risk of skin cancer in patients with inflammatory bowel disease
    Clowry, J.
    Sheridan, J.
    Keegan, D.
    Byrne, K.
    Comber, H.
    Deady, S.
    Cullen, G.
    Mulcahy, H.
    Doherty, G.
    Lally, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 105 - 105
  • [9] Cancer prevention in inflammatory bowel disease as a treatment goal
    Ekbom, A
    TARGETS OF TREATMENT IN CHRONIC INFLAMMATORY BOWEL DISEASES, 2003, 131 : 214 - 219
  • [10] INFLAMMATORY BOWEL DISEASE AND SKIN CANCER: A SURVEY OF PHYSICIAN MANAGEMENT
    Ogrich, Lauren
    Nadhan, Kumar
    Nandi, Neilanjan
    Boyle, Suzanne
    Chung, Christina
    GASTROENTEROLOGY, 2017, 152 (05) : S582 - S582
12345